RolainJMBrouquiPKoehlerJEMaguinaCDolanMJRaoultD. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother. 2004;48(6):1921-1933.
2.
Maiques-TobiasETomatis-SouverbielleCWatsonJRamiloOMejiasA. Enfermedad diseminada por arañazo de gato: el amplio espectro de la presentación [Disseminated cat scratch disease: the wide variety of clinical presentations]. An Pediatr (Engl Ed). 2019;90(6):393-395.
3.
HajjajiNHocquelouxLKerdraonRBretL. Bone infection in cat-scratch disease: a review of the literature. J Infect. 2007;54(5):417-421.
4.
ArisoyESCorreaAGWagnerMLKaplanSL. Hepato-splenic cat-scratch disease in children: selected clinical features and treatment. Clin Infect Dis. 1999;28(4):778-784. doi: 10.1086/515197.
5.
JaruratanasirikulSHortiwakulRTantisarasartTPhuenpathomNTussanasunthornwongS. Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye. Antimicrob Agents Chemother. 1996;40(3):825-826.
6.
ToddSRDahlgrenFSTraegerMS, et al. No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever. J Pediatr. 2015;166(5):1246-1251.
7.
BhattiMTLeeMS. Should patients with Bartonella neuroretinitis receive treatment?J Neuroophthalmol. 2014;34(4):412-416.
